Apellis Pharmaceuticals Cash from Operations (TTM) Analysis

Apellis Pharmaceuticals Inc (APLS)

48.68 +1.04 (+2.18%) USD | NASDAQ | Apr 23, 16:00

48.68 0.00 (0.00%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	-594.74M
September 30, 2023	-637.60M
June 30, 2023	-622.94M
March 31, 2023	-579.80M
December 31, 2022	-513.74M
September 30, 2022	-485.50M
June 30, 2022	-499.71M
March 31, 2022	-521.37M
December 31, 2021	-563.13M
September 30, 2021	-308.65M
June 30, 2021	-239.85M
March 31, 2021	-205.45M
December 31, 2020	-160.49M

Date	Value
September 30, 2020	-384.54M
June 30, 2020	-338.31M
March 31, 2020	-283.92M
December 31, 2019	-211.14M
September 30, 2019	-173.54M
June 30, 2019	-153.08M
March 31, 2019	-143.87M
December 31, 2018	-131.24M
September 30, 2018	-102.30M
June 30, 2018	-80.30M
March 31, 2018	-61.10M
December 31, 2017	-46.60M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-637.60M

Minimum

Sep 2023

-153.08M

Maximum

Jun 2019

-393.55M

Average

-384.54M

Median

Sep 2020

Cash from Operations (TTM) Benchmarks